Evidence map›Paper›PMID 42193276›Full record

ArticleBiomedicines2026

Characterizing Response to PARP Inhibitor Treatment Combinations in Advanced Prostate Cancer.

Bryan Correa Gonzalez, Akshaya Karthikeyan, Love A Moore, Anamitra Bhaumik, Ethan Sandoval, Marion Hardy, John D McPherson, Hong Li, Mamta Parikh, Marc Dall'Era and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bryan Correa GonzalezDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Akshaya KarthikeyanDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.ORCID 0009-0006-2939-8958
Love A MooreDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Anamitra BhaumikDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Ethan SandovalDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Marion HardyDepartment of Molecular and Cellular Biology, University of California, Davis, Davis, CA 95616, USA.ORCID 0009-0002-5190-0722
John D McPhersonDepartment of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Hong LiComprehensive Cancer Center, University of California, Davis, Sacramento, CA 95817, USA.
Mamta ParikhComprehensive Cancer Center, University of California, Davis, Sacramento, CA 95817, USA.
Marc Dall'EraDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Allen C GaoDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.
Alan P LombardDepartment of Urologic Surgery, University of California, Davis, Sacramento, CA 95817, USA.

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI KC KENT LLOYD · 2002 to 2026
$84.9M
NCI NIH HHS P30 CA093373NIH HHS 1K01CA262351-01NIH HHS P30CA093373NIH HHS T32GM153586-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AR-pathway inhibitorATM inhibitorlartesertibPARP inhibitorprostate cancer

Identifiers

PMID42193276
PMCPMC13203762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.